5Bottomley A, Coens C, Efficace F, et al. Symptoms and patientreported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTCNCIC08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.J Clin Oncol,2007; 25: 5770-5776.
6Waller DA, Morritt GN, Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion.Chest 1995; 107: 1454-1456.
7Soysal O, Karaoglanoglu N, Demiracan S, et al. Pleurectomy/ decortication for palliation in malignant pleural mesothelioma:results of surgery. EurJ Cardiothorac Surg 1997; 11: 210-213.
8Halstead JC, Lim E, Venkateswaran RM, et al. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Eur J Surg Oncol 2005; 31: 314-320.
9Nakas A, Martin Ucar AE, Edwards JG, et al. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008; 33: 83-88.
10Martin-Ucar AE, Edwards JG, Rengajaran A, et al. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. EurJ Cardiothorac Surg 2001; 20:1117-1121.
